Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wesley R Armstrong

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 22, 2019
Total-Body <sup>68</sup>Ga-PSMA-11 PET/CT for Bone Metastasis Detection in Prostate Cancer Patients: Potential Impact on Bone Scan GuidelinesKelsey L Pomykala, Johannes Czernin, Tristan R Grogan, et al.
European Urology Focus|January 2, 2021
Update from PSMA-SRT Trial NCT03582774: A Randomized Phase 3 Imaging Trial of Prostate-specific Membrane Antigen Positron Emission Tomography for Salvage Radiation Therapy for Prostate Cancer Recurrence Powered for Clinical OutcomeJeremie Calais, Wesley R Armstrong, Amar U Kishan, et al.
Immunity|February 19, 2026
The transcriptional repressor Fli1 inhibits proteostasis during nutrient stress to limit NK cell persistence in solid tumorsJeong Hyun Ji, Wesley R Armstrong, Joey H Li, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 23, 2025
Kinetics of PSMA PET signal after radiotherapy in prostate cancer lesions: A single-center retrospective studyMasatoshi Hotta, Kathleen Nguyen, Pan Thin, et al.
Annals of Surgical Oncology|June 22, 2024
Larger Tumor Size and Elevated Serum Chromogranin A Levels Predict Metastatic Disease on DOTATATE Imaging in Patients with Gastroenteropancreatic Neuroendocrine TumorsAmanda Labora, Takayuki Shimizu, Alexandra Moore, et al.
Clinical Nuclear Medicine|May 5, 2023
FAPI PET Signal in Hibernoma Reflects FAP Expression in Tumor Vasculature CellsMasatoshi Hotta, Christine E Mona, Joseph G Crompton, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 29, 2022
Measuring response in metastatic castration-resistant prostate cancer using PSMA PET/CT: comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 criteriaAndrei Gafita, Isabel Rauscher, Wolfgang P Fendler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 17, 2021
18F-FDG PET/CT Imaging Biomarkers for Early and Late Evaluation of Response to First-Line Chemotherapy in Patients with Pancreatic Ductal AdenocarcinomaMatthias R Benz, Wesley R Armstrong, Francesco Ceci, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 29, 2021
The Impact of Monosodium Glutamate on <sup>68</sup>Ga-PSMA-11 Biodistribution in Men with Prostate Cancer: A Prospective Randomized, Controlled Imaging StudyWesley R Armstrong, Andrei Gafita, Shaojun Zhu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 2021
<sup>18</sup>F-FLT PET/CT as a Prognostic Imaging Biomarker of Disease-Specific Survival in Patients with Primary Soft-Tissue SarcomaJoseph G Crompton, Wesley R Armstrong, Mark A Eckardt, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 22, 2019
Total-Body <sup>68</sup>Ga-PSMA-11 PET/CT for Bone Metastasis Detection in Prostate Cancer Patients: Potential Impact on Bone Scan GuidelinesKelsey L Pomykala, Johannes Czernin, Tristan R Grogan, et al.
European Urology Focus|January 2, 2021
Update from PSMA-SRT Trial NCT03582774: A Randomized Phase 3 Imaging Trial of Prostate-specific Membrane Antigen Positron Emission Tomography for Salvage Radiation Therapy for Prostate Cancer Recurrence Powered for Clinical OutcomeJeremie Calais, Wesley R Armstrong, Amar U Kishan, et al.
Immunity|February 19, 2026
The transcriptional repressor Fli1 inhibits proteostasis during nutrient stress to limit NK cell persistence in solid tumorsJeong Hyun Ji, Wesley R Armstrong, Joey H Li, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 23, 2025
Kinetics of PSMA PET signal after radiotherapy in prostate cancer lesions: A single-center retrospective studyMasatoshi Hotta, Kathleen Nguyen, Pan Thin, et al.
Annals of Surgical Oncology|June 22, 2024
Larger Tumor Size and Elevated Serum Chromogranin A Levels Predict Metastatic Disease on DOTATATE Imaging in Patients with Gastroenteropancreatic Neuroendocrine TumorsAmanda Labora, Takayuki Shimizu, Alexandra Moore, et al.
Clinical Nuclear Medicine|May 5, 2023
FAPI PET Signal in Hibernoma Reflects FAP Expression in Tumor Vasculature CellsMasatoshi Hotta, Christine E Mona, Joseph G Crompton, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 29, 2022
Measuring response in metastatic castration-resistant prostate cancer using PSMA PET/CT: comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 criteriaAndrei Gafita, Isabel Rauscher, Wolfgang P Fendler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 17, 2021
18F-FDG PET/CT Imaging Biomarkers for Early and Late Evaluation of Response to First-Line Chemotherapy in Patients with Pancreatic Ductal AdenocarcinomaMatthias R Benz, Wesley R Armstrong, Francesco Ceci, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 29, 2021
The Impact of Monosodium Glutamate on <sup>68</sup>Ga-PSMA-11 Biodistribution in Men with Prostate Cancer: A Prospective Randomized, Controlled Imaging StudyWesley R Armstrong, Andrei Gafita, Shaojun Zhu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 2021
<sup>18</sup>F-FLT PET/CT as a Prognostic Imaging Biomarker of Disease-Specific Survival in Patients with Primary Soft-Tissue SarcomaJoseph G Crompton, Wesley R Armstrong, Mark A Eckardt, et al.
Pageof 3